What Is Fibromyalgia?
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, and a heightened sensitivity to touch. Often described as a “invisible illness,” it doesn’t show up on blood tests or imaging scans, which can make diagnosis a lengthy and frustrating journey for those who live with it. The disorder is believed to involve how the brain and spinal cord process pain signals, amplifying sensations that would normally be harmless.
Who Is Affected?
Globally, fibromyalgia is estimated to impact 2–8% of the population, with women outnumbering men by roughly a 3:1 ratio. It typically emerges in middle adulthood, although children and adolescents can also develop symptoms. Because the condition is frequently misunderstood, many sufferers report a delay of several years between the onset of pain and an official diagnosis.
Common Symptoms
Widespread pain: A dull ache that lasts for at least three months, often affecting both sides of the body and above and below the waist.
Fatigue: Even after a full night’s sleep, many people feel unrested and low on energy.
Cognitive difficulties: Commonly called “fibro fog,” this includes trouble concentrating, memory lapses, and difficulty multitasking.
Sleep disturbances: Light or fragmented sleep that fails to restore vigour.
Other hallmark features: Headaches, irritable bowel syndrome (IBS), temporomandibular joint (TMJ) disorders, and mood swings often accompany the core symptoms.
Causes and Triggers
The exact cause remains elusive, but research points to a combination of genetic, environmental, and psychological factors:
Genetic predisposition: Family history can increase susceptibility.
Physical or emotional trauma: Severe injuries, surgeries, or prolonged stress may trigger or exacerbate the condition.
Infections: Some viral or bacterial infections appear to spark flare‑ups in predisposed individuals.
Abnormal pain processing: Neuroimaging studies reveal heightened activity in brain regions that interpret pain, suggesting a “pain amplification” system.
Diagnosing Fibromyalgia
Because there is no definitive laboratory test, clinicians rely on a recognised set of criteria. The most widely used approach involves:
Widespread Pain Index (WPI) – Counting the number of painful areas over the past week.
Symptom Severity (SS) Scale – Rating the severity of fatigue, unrefreshing sleep, and cognitive symptoms.
A diagnosis is typically made when a person has experienced widespread pain for more than three months and the symptom severity reaches a certain threshold, after other conditions (e.g., rheumatoid arthritis, lupus) have been ruled out.
Chronic Fatigue Syndrome
One of the most striking features of fibromyalgia is its frequent co‑occurrence with chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). Research shows that 50–70 % of people diagnosed with fibromyalgia also meet the diagnostic criteria for chronic fatigue syndrome. The two conditions share many symptoms—most notably profound fatigue, non‑restorative sleep, and cognitive fog—which often makes it difficult to tell where one ends and the other begins.
Iron Metabolism
Even though fibromyalgia (FM) and chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) frequently co‑occur, the two disorders appear to affect iron metabolism in opposite directions, and this apparent paradox can be understood by looking at the underlying biology and the way studies are designed. Serum ferritin is not a static trait marker but a acute‑phase reactant that rises with inflammation and falls when iron stores are low or when chronic disease‑related anemia of the “iron‑restriction” type is present; therefore, a high ferritin in CFS/ME likely reflects the pronounced immune activation and cytokine‑driven hepatic ferritin synthesis that characterises that illness, whereas a low ferritin in FM may stem from a different inflammatory milieu, possibly driven by neuro‑endocrine dysregulation, pain‑related malnutrition, or frequent use of analgesics that alter iron absorption. When a patient harbours both conditions, the biomarker need not simply be the arithmetic average of the two patterns because the dominant pathophysiology—often the one that is most active or clinically salient at the time of sampling—can mask the contribution of the other; moreover, studies often recruit “pure” groups to increase statistical power, and they may not adequately represent the subset with true comorbidity, so the mixed characteristics that you would expect in practice are not always captured in group‑level comparisons. Consequently, the contradictory ferritin findings do not disprove comorbidity; rather, they illustrate how a single laboratory value can be pulled in opposite directions by distinct mechanistic pathways, and why the clinical picture in a person with both FM and CFS/ME may fluctuate depending on which disease process is prevailing at the moment the blood is drawn.
This overlap has important implications:
Complex symptom management: Treating pain may not resolve fatigue, and vice versa, requiring a more holistic approach.
Integrated care: Many clinicians now recommend a combined treatment plan that addresses both pain and energy levels, rather than focussing on a single symptom.
Research synergy: Studies that investigate the underlying mechanisms of one condition often shed light on the other, fostering cross‑disciplinary breakthroughs.
Living with Fibromyalgia
For those navigating life with fibromyalgia (and often CFS), daily strategies can make a significant difference:
Pacing activities: Break tasks into smaller chunks, allowing rest periods to prevent “boom‑bust” cycles of over‑exertion and flare‑ups.
Prioritising sleep hygiene: Keep a consistent bedtime, limit screen time before sleep, and create a cool, dark environment.
Gentle movement: Short walks, swimming, or tai chi can improve circulation and reduce stiffness without overtaxing the body.
Nutrition: Anti‑inflammatory foods (omega‑3 fatty acids, berries, leafy greens) may help mitigate some pain, while caffeine and refined sugars can exacerbate fatigue.
Mental health: Seeking counselling or joining a support network can provide emotional resilience and reduce the psychological burden of chronic illness.
Research Horizons
The scientific community continues to pursue a deeper understanding of fibromyalgia. Emerging areas of investigation include:
Biomarker discovery: Searching for objective markers (e.g., inflammatory cytokines, genetic signatures) that could aid diagnosis.
Neuromodulation: Techniques such as transcranial magnetic stimulation (TMS) and neurofeedback are being studied for pain reduction.
Personalised medicine: Tailoring treatment based on individual genetic profiles and symptom clusters holds promise for more effective care.
Conclusion
Fibromyalgia remains a complex, often misunderstood disorder that touches every facet of life—physical, emotional, and social. While there is no cure yet, a combination of medication, therapy, lifestyle changes, and strong support networks can help individuals regain control and improve their well‑being. The substantial overlap with chronic fatigue syndrome underscores the need for a comprehensive, patient‑centred approach that addresses both pain and persistent fatigue.
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you suspect you have fibromyalgia or chronic fatigue syndrome, please consult a qualified healthcare provider.
—
Recommended reading:
Fibromyalgia: Understanding And Getting Relief From Pain That Won’t Go Away, by Dr Don. L. Goldenberg
Worldwide Temple of Aurora 